Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Perrigo And Sol-Gel Face Up To Duobrii Lawsuit

ANDA Filed By Perrigo In July

Sep 08 2020

• By Dean Rudge

Gavel — Perrigo sent the originator a Paragraph IV patent challenge certification on 23 July • Source: Shutterstock

Related Content

Perrigo Bolsters US Generics Ahead Of Separation Plans

Jul 01 2020

Related Companies

Perrigo Company PLC

Additional Topics

United States Intellectual Property Legal Issues Generic Drugs Dermatology BioPharmaceutical

More from Legal & IP

More from Generics Bulletin

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.